semaglutide through hers Digital pharmacy to offer weight-loss drug cheaper than Ozempic Hims & Hers Stock Pops

Eli Lilly announced theyre planning to submit orforglipron to the FDA for weight loss this year

Health authorities have warned that some compounded GLP-1 products may contain incorrect doses, different chemical formulations, or additional ingredients whose safety and effectiveness have not been established

Different research groups and funders have different priorities, ranging from more immediate protection against all variants of single species, such as SARS-CoV-2, to the long-term ambitious goal of protection against future pandemics

If youre considering GLP-1 agonists for weight loss, ask yourself: Is this the best solution for me, or am I taking resources away from those who truly need them